title: The addition of rituximab to fludarabine and cyclophosphamide improves progression-free survival in patients with previously treated chronic lymphocytic leukemia.
authors.affiliation: Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
authors.forename: Amit
authors.initials: A
authors.lastname: Mahipal
authors.forename: Mark
authors.initials: M
authors.lastname: Weiss
references.citation: J Clin Oncol. 2006 Apr 1;24(10):1575-81
references.pmid: 16520464
references.citation: J Clin Oncol. 2003 Apr 1;21(7):1278-84
references.pmid: 12663715
references.citation: J Clin Oncol. 2010 Apr 1;28(10):1756-65
references.pmid: 20194844
references.citation: Blood. 2006 Feb 1;107(3):885-91
references.pmid: 16219797
references.citation: Lancet. 2008 Mar 22;371(9617):1017-29
references.pmid: 18358929
references.citation: J Clin Oncol. 2005 Jun 20;23(18):4070-8
references.pmid: 15767647
references.citation: J Clin Oncol. 2009 Feb 1;27(4):491-7
references.pmid: 19075280
references.citation: J Clin Oncol. 2009 Feb 1;27(4):498-503
references.pmid: 19075274
references.citation: Blood. 2009 Oct 15;114(16):3382-91
references.pmid: 19605849
references.citation: Blood. 2008 Aug 15;112(4):975-80
references.pmid: 18411418